Scholarlink

Background <p>Dyslipidemia remains a major modifiable contributor to China’s cardiovascular disease (CVD) burden, yet large-scale evidence on risk-stratified management gaps is lacking.</p> Methods <p>In this nationwide study across 1,785 hospitals in 28 Chinese provinces, 604,250 outpatients with dyslipidemia were enrolled. We analyzed lipid levels, quantified control rate among treated population and rates of requiring lipid-lowering therapy (LLT) among untreated population across regions, socioeconomic status, and demographic groups.</p> Results <p>Total cholesterol (TC) and low-density lipoprotein cholesterol (LDL-C) levels were higher among females, middle-aged individuals, and individuals with obesity. LDL-C levels were also higher among urban residents, while TC showed no significant urban-rural difference. Triglyceride (TG) levels were higher in males, middle-aged individuals, individuals with obesity, and rural residents. Among treated population, LDL-C/non-HDL-C control rates reached 95% in low-risk, 70–90% in moderate-risk, 40–50% in high-risk, and 5–15% in very-high-risk groups. Among untreated population, rates of requiring LLT reached about 20% in the low-risk group and over 70% in moderate- and high-risk groups. After adjusting for covariates, males, older individuals, smokers, patients with hypertension or type 2 diabetes mellitus, as well as those in rural and low-gross-domestic-product areas were associated with lower lipid control rates and higher treatment needs.</p> Conclusions <p>Our findings highlight the urgent need for risk-stratified lipid management in primary care, improved access to LLT, and policies addressing regional and socioeconomic disparities to enhance lipid control and reduce CVD burden in China. Lessons from China can inform global strategies to improve lipid management and reduce the CVD burden.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Lipid levels and risk-stratified management gaps of dyslipidemia in China

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年5月2日

查看全文
  • Long Zhang,
  • Xu Liu,
  • Fangfang Fan,
  • Mei Zhang,
  • Zhihao Liu,
  • Zuoyi Zhou,
  • Yaokun Liu,
  • Tieci Yi,
  • Yuxi Li,
  • Shengcong Liu,
  • Haoyu Weng,
  • Yixue Zhao,
  • Leyi Wang,
  • Yangyang Sun,
  • Chao Zhai,
  • Jingwei Bian,
  • Junguo Jin,
  • Rujie Zheng,
  • Jia Jia,
  • Yan Chen,
  • Luya Wang,
  • Yanwen Qin,
  • Hu Ding,
  • Zhenyan Fu,
  • Maigeng Zhou,
  • Shuduo Zhou,
  • Yan Zhang,
  • Jianping Li

摘要

Background

Dyslipidemia remains a major modifiable contributor to China’s cardiovascular disease (CVD) burden, yet large-scale evidence on risk-stratified management gaps is lacking.

Methods

In this nationwide study across 1,785 hospitals in 28 Chinese provinces, 604,250 outpatients with dyslipidemia were enrolled. We analyzed lipid levels, quantified control rate among treated population and rates of requiring lipid-lowering therapy (LLT) among untreated population across regions, socioeconomic status, and demographic groups.

Results

Total cholesterol (TC) and low-density lipoprotein cholesterol (LDL-C) levels were higher among females, middle-aged individuals, and individuals with obesity. LDL-C levels were also higher among urban residents, while TC showed no significant urban-rural difference. Triglyceride (TG) levels were higher in males, middle-aged individuals, individuals with obesity, and rural residents. Among treated population, LDL-C/non-HDL-C control rates reached 95% in low-risk, 70–90% in moderate-risk, 40–50% in high-risk, and 5–15% in very-high-risk groups. Among untreated population, rates of requiring LLT reached about 20% in the low-risk group and over 70% in moderate- and high-risk groups. After adjusting for covariates, males, older individuals, smokers, patients with hypertension or type 2 diabetes mellitus, as well as those in rural and low-gross-domestic-product areas were associated with lower lipid control rates and higher treatment needs.

Conclusions

Our findings highlight the urgent need for risk-stratified lipid management in primary care, improved access to LLT, and policies addressing regional and socioeconomic disparities to enhance lipid control and reduce CVD burden in China. Lessons from China can inform global strategies to improve lipid management and reduce the CVD burden.